Tapeworm Drug May Hold Promise For Colon Cancer, Future Research
(PhysOrg.com) -- Duke University Medical Center researchers have discovered an already-FDA-approved compound that can effectively “silence” a cell receptor shown to interfere with chemotherapy.
